RMD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RMD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
ResMed's inventories, raw materials & components for the quarter that ended in Dec. 2024 was $365 Mil.
ResMed's quarterly raw materials increased from Jun. 2024 ($356 Mil) to Sep. 2024 ($373 Mil) but then declined from Sep. 2024 ($373 Mil) to Dec. 2024 ($365 Mil).
ResMed's annual raw materials increased from Jun. 2022 ($355 Mil) to Jun. 2023 ($459 Mil) but then declined from Jun. 2023 ($459 Mil) to Jun. 2024 ($356 Mil).
The historical data trend for ResMed's Inventories, Raw Materials & Components can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ResMed Annual Data | |||||||||||||||||||||
Trend | Jun15 | Jun16 | Jun17 | Jun18 | Jun19 | Jun20 | Jun21 | Jun22 | Jun23 | Jun24 | |||||||||||
Inventories, Raw Materials & Components | Get a 7-Day Free Trial |
![]() |
![]() |
128.10 | 155.42 | 355.23 | 459.13 | 355.57 |
ResMed Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Inventories, Raw Materials & Components | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
467.22 | 406.64 | 355.57 | 373.29 | 364.81 |
Materials and components scheduled for use in making a product.
Kaushik Ghoshal | officer: President, SaaS Business | 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123 |
Brett Sandercock | officer: Chief Financial Officer | 17 GUINEVIERE COURT, CASTLE HILL, NEW SOUTH WALES C3 2154 |
Michael J. Farrell | officer: Chief Executive Officer | C/O REMED INC, 9001 SPECTRUM CTR. BLVD., SAN DIEGO, CA 92123 |
Peter C Farrell | director | RESMED INC, 14040 DANIELSON STREET, POWAY CA 92064-6857 |
Michael J Rider | officer: Global General Counsel | 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123 |
Justin Leong | officer: President, Asia and LATAM | C/O RESMED INC, 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123 |
Witte Jan De | director | C/O RESMED INC., 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123 |
Karen Drexler | director | C/O DIADEXUS, INC., 343 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080 |
Robert Andrew Douglas | officer: President and COO | 21 ATTUNGA ROAD, NEWPORT, NEW SOUTH WALES C3 2106 |
David Pendarvis | officer: Chief Administration Officer | REDMED INC, 14040 DANLELSON ST, POWAY CA 92064 |
Desney Tan | director | 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123 |
John Hernandez | director | 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123 |
Lucile Blaise | officer: President, Sleep & RC Business | RESMED INC., 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123 |
James Hollingshead | officer: President, Sleep Business | C/O RESMED INC., 9001 SPECTRUM CENTER BOULEVARD, SAN DIEGO CA 92123 |
Carol Burt | director | C/O WELLCARE HEALTH PLANS, INC., 8725 HENDERSON ROAD, TAMPA FL 33634 |
From GuruFocus
By GuruFocus News • 02-01-2025
By GuruFocus News • 01-31-2025
By GuruFocus News • 11-25-2024
By GuruFocus News • 02-26-2025
By GuruFocus News • 12-11-2024
By GuruFocus News • 11-14-2024
By Marketwired • 03-19-2025
By Marketwired • 01-30-2025
By GuruFocus News • 01-06-2025
By Marketwired • 03-11-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.